Search

Your search keyword '"Kovari H"' showing total 276 results

Search Constraints

Start Over You searched for: Author "Kovari H" Remove constraint Author: "Kovari H"
276 results on '"Kovari H"'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

3. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

4. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. Time Trends in Causes of Death in People With Human Immunodeficiency Virus: Insights From the Swiss HIV Cohort Study

6. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

7. Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study.

8. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

9. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

10. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

11. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

12. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

13. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

14. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

15. Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study

16. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

17. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

18. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

19. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

20. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

21. A highly virulent variant of HIV-1 circulating in the Netherlands

22. Children living with HIV in Europe: do migrants have worse treatment outcomes?

23. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

24. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

25. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

26. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

27. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

28. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

30. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

31. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

33. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile

34. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?

35. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

36. Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

37. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

38. J Int AIDS Soc

39. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

40. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

41. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study

42. Pulmonary Toxoplasmosis, a Rare but Severe Manifestation of a Common Opportunistic Infection in Late HIV Presenters: Report of Two Cases

43. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

44. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

45. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

46. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

47. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

48. Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

49. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population

50. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

Catalog

Books, media, physical & digital resources